These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 9059849)

  • 1. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Sheu JR; Chao SH; Yen MH; Huang TF
    Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
    Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments.
    Sheu JR; Hung WC; Wu CH; Lee YM; Yen MH
    Br J Haematol; 2000 Jul; 110(1):110-5. PubMed ID: 10930986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
    Sheu JR; Hsiao G; Lee YM; Yen MH
    Int J Hematol; 2001 Apr; 73(3):393-8. PubMed ID: 11345210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.
    Wu CC; Kuo SC; Lee FY; Teng CM
    Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.
    Hsiao G; Yen MH; Lee YM; Sheu JR
    Br J Haematol; 2002 Jun; 117(3):699-704. PubMed ID: 12028044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
    Sheu JR; Huang TF
    J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo.
    Hsiao G; Shen MY; Lin KH; Chou CY; Tzu NH; Lin CH; Chou DS; Chen TF; Sheu JR
    Eur J Pharmacol; 2003 Apr; 465(3):281-7. PubMed ID: 12681440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
    Shchegolev AIu; Sidorova TA; Severina IS
    Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Cwiklicki A; Rehse K
    Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
    Hering KW; Artz JD; Pearson WH; Marletta MA
    Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
    Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
    Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.